TNDM · Tandem Diabetes Care, Inc.

On May 11, 2026, Tandem Diabetes Care notified Mark Novara, its Executive Vice President and Chief Commercial Officer, that his employment would be terminated without cause, with his last day scheduled for May 18, 2026. The company explicitly stated that its strategy and 2026 goals remain unchanged, suggesting that the termination is not driven by a shift in business direction. However, the sudden departure of a senior commercial leader, without immediate announcement of a successor or interim plan, introduces near-term execution risk, particularly in sales and commercial strategy. Investors should monitor for further announcements regarding leadership succession and any potential impact on revenue growth or market share.